Literature DB >> 12921602

[Study on the myocardiac injury in patients with severe acute respiratory syndrome].

Yu-juan Guan1, Xiao-ping Tang, Chi-biao Yin, Wen-xin Hong, Chun-liang Lei.   

Abstract

OBJECTIVE: To explore the myocardiac injury in patients with severe acute respiratory syndrome (SARS) and its clinical significance.
METHODS: 37 SARS patients fulfilled the Guangdong provincial diagnostic criteria for infectious atypical pneumonia and 35 health controls were investigated. The serum levels of creatine kinase (CK), lactate dehydrogenase (LDH), aspartate transaminase (AST), troponin I (TnI), creatine kinase-MB (CK-MB) and myoglobin (MYO) were measured.
RESULTS: CK, LDH and AST levels in patients were higher than those of control group (P < 0.01); furthermore, among patients the levels were higher in fatal cases than in survivors. The positive rates of TnI, CK-MB and MYO in patients were higher than those in controls (P < 0.05).
CONCLUSION: The patients with SARS are subject to complicating myocardiac injury. Therefore, careful monitoring of the myocardiac enzyme profiles is of great importance in reducing the complications and mortality in patients with SARS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12921602

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  2 in total

1.  Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis.

Authors:  Jia-Fu Wei; Fang-Yang Huang; Tian-Yuan Xiong; Qi Liu; Hong Chen; Hui Wang; He Huang; Yi-Chun Luo; Xuan Zhou; Zhi-Yue Liu; Yong Peng; Yuan-Ning Xu; Bo Wang; Ying-Ying Yang; Zong-An Liang; Xue-Zhong Lei; Yang Ge; Ming Yang; Ling Zhang; Ming-Quan Zeng; He Yu; Kai Liu; Yu-Heng Jia; Bernard D Prendergast; Wei-Min Li; Mao Chen
Journal:  Heart       Date:  2020-04-30       Impact factor: 5.994

Review 2.  A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.

Authors:  Aishwarya Gulati; Corbin Pomeranz; Zahra Qamar; Stephanie Thomas; Daniel Frisch; Gautam George; Ross Summer; Joseph DeSimone; Baskaran Sundaram
Journal:  Am J Med Sci       Date:  2020-05-11       Impact factor: 2.378

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.